Full Text
Advanced Search

Toxicology Research

A multidisciplinary journal covering high impact research in fundamental, translational and applied areas of toxicology; the official journal of The British Toxicology Society and The Chinese Society of Toxicology


Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi

Corresponding authors
Millennium Pharmaceuticals, Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, USA
E-mail: Vilmos.Csizmadia@Takeda.com
Fax: +1 617-444-1501
Tel: +1 617-551-3620
Toxicol. Res., 2016, Advance Article

DOI: 10.1039/C6TX00220J
Received 19 May 2016, Accepted 23 Aug 2016
First published online 25 Aug 2016
Open Access
Please wait while Download options loads
This article has not yet been cited.